Man Industries (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:46 am

Competitors of Man Industries (India) Ltd

All Competitor Stocks of Man Industries (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:20 am

Below is a detailed analysis of the quarterly data for Man Industries (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 742.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,218.00 Cr. (Mar 2025) to 742.00 Cr., marking a decrease of 476.00 Cr..
• For Expenses, as of Jun 2025, the value is 693.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,097.00 Cr. (Mar 2025) to 693.00 Cr., marking a decrease of 404.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 72.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 7.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 16.00 Cr..
• For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 35.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 53.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 28.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 40.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.11. The value appears to be declining and may need further review. It has decreased from 10.53 (Mar 2025) to 4.11, marking a decrease of 6.42.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:55 am

Balance Sheet

Last Updated: May 13, 2025, 3:09 pm

Below is a detailed analysis of the balance sheet data for Man Industries (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,575.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,372.00 Cr. (Mar 2024) to 1,575.00 Cr., marking an increase of 203.00 Cr..
• For Borrowings, as of Mar 2025, the value is 476.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 326.00 Cr. (Mar 2024) to 476.00 Cr., marking an increase of 150.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,696.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 684.00 Cr. (Mar 2024) to 1,696.00 Cr., marking an increase of 1,012.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,415.00 Cr. (Mar 2024) to 3,779.00 Cr., marking an increase of 1,364.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 643.00 Cr.. The value appears strong and on an upward trend. It has increased from 605.00 Cr. (Mar 2024) to 643.00 Cr., marking an increase of 38.00 Cr..
• For CWIP, as of Mar 2025, the value is 133.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 133.00 Cr., marking an increase of 102.00 Cr..
• For Investments, as of Mar 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 228.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 202.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,977.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,552.00 Cr. (Mar 2024) to 2,977.00 Cr., marking an increase of 1,425.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,779.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,415.00 Cr. (Mar 2024) to 3,779.00 Cr., marking an increase of 1,364.00 Cr..

Notably, the Reserves (1,575.00 Cr.) exceed the Borrowings (476.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Man Industries (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.66. This value is within the healthy range. It has increased from 17.42 (Mar 24) to 23.66, marking an increase of 6.24.
• For Diluted EPS (Rs.), as of Mar 25, the value is 22.78. This value is within the healthy range. It has increased from 16.73 (Mar 24) to 22.78, marking an increase of 6.05.
• For Cash EPS (Rs.), as of Mar 25, the value is 30.65. This value is within the healthy range. It has increased from 25.68 (Mar 24) to 30.65, marking an increase of 4.97.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 248.26. It has increased from 217.02 (Mar 24) to 248.26, marking an increase of 31.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 248.26. It has increased from 217.02 (Mar 24) to 248.26, marking an increase of 31.24.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 541.45. It has increased from 485.39 (Mar 24) to 541.45, marking an increase of 56.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 54.56. This value is within the healthy range. It has increased from 45.30 (Mar 24) to 54.56, marking an increase of 9.26.
• For PBIT / Share (Rs.), as of Mar 25, the value is 47.57. This value is within the healthy range. It has increased from 35.86 (Mar 24) to 47.57, marking an increase of 11.71.
• For PBT / Share (Rs.), as of Mar 25, the value is 32.18. This value is within the healthy range. It has increased from 22.29 (Mar 24) to 32.18, marking an increase of 9.89.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.66. This value is within the healthy range. It has increased from 16.24 (Mar 24) to 23.66, marking an increase of 7.42.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.66. This value is within the healthy range. It has increased from 16.24 (Mar 24) to 23.66, marking an increase of 7.42.
• For PBDIT Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 10.07, marking an increase of 0.74.
• For PBIT Margin (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.38 (Mar 24) to 8.78, marking an increase of 1.40.
• For PBT Margin (%), as of Mar 25, the value is 5.94. This value is below the healthy minimum of 10. It has increased from 4.59 (Mar 24) to 5.94, marking an increase of 1.35.
• For Net Profit Margin (%), as of Mar 25, the value is 4.36. This value is below the healthy minimum of 5. It has increased from 3.34 (Mar 24) to 4.36, marking an increase of 1.02.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.36. This value is below the healthy minimum of 8. It has increased from 3.34 (Mar 24) to 4.36, marking an increase of 1.02.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 15. It has increased from 7.48 (Mar 24) to 9.52, marking an increase of 2.04.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.16. This value is within the healthy range. It has increased from 14.64 (Mar 24) to 17.16, marking an increase of 2.52.
• For Return On Assets (%), as of Mar 25, the value is 4.05. This value is below the healthy minimum of 5. It has decreased from 4.35 (Mar 24) to 4.05, marking a decrease of 0.30.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.28. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.28, marking an increase of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.13. It has decreased from 1.52 (Mar 24) to 1.13, marking a decrease of 0.39.
• For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.92 (Mar 24) to 1.39, marking a decrease of 0.53.
• For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.74, marking a decrease of 0.41.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.44. This value is below the healthy minimum of 4. It has decreased from 6.49 (Mar 24) to 2.44, marking a decrease of 4.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.43 (Mar 24) to 0.00, marking a decrease of 11.43.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.23 (Mar 24) to 0.00, marking a decrease of 7.23.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.57 (Mar 24) to 0.00, marking a decrease of 88.57.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.77 (Mar 24) to 0.00, marking a decrease of 92.77.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.55. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 3.55, marking an increase of 0.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.54. This value is below the healthy minimum of 3. It has increased from 2.20 (Mar 24) to 2.54, marking an increase of 0.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,802.41. It has decreased from 2,378.24 (Mar 24) to 1,802.41, marking a decrease of 575.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.51, marking a decrease of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 5.10. This value is within the healthy range. It has decreased from 8.11 (Mar 24) to 5.10, marking a decrease of 3.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.49, marking a decrease of 0.24.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.56 (Mar 24) to 0.00, marking a decrease of 88.56.
• For Price / BV (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.07, marking a decrease of 0.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 24) to 0.49, marking a decrease of 0.24.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness